(877) 320-5131 Menu
(877) 320-5131
Contact
Patient Portal

Upcoming

Astellas: An Open-Label, Multicenter, Multi-Cohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202):


Bayer : An open-label, multi-center, phase 1b/2 study to evaluate thesafety and efficacy of copanlisib in combination with nivolumabin patients with advanced solid tumors:


Lilly: J2K-MC-JZKA: A Phase 1/2 Study of LY3499446 Administered to Patients with AdvancedSolid Tumors with KRAS G12C mutation:"


Mirati phase 1/2 (Basket) - A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation:

For more information about Beverly Hills Cancer Center's comprehensive clinical research programs and trials currently available to patients, please contact us at (310) 432-8932 or click here to send in an inquiry.

Schedule a Consultation

Your health is important, and we welcome the opportunity to help you heal.


To schedule an appointment, please call Beverly Hills Cancer Center in Beverly Hills, California at (877) 320-5131 or Click the link below to access our Online Appointment Request

Book An Appointment

© Beverly Hills Cancer Center. All Rights Reserved. Web Design & Internet Marketing by Studio III

Privacy Policy

Rate Us
Rate us on Google Rate us on Yelp Rate us on HealthGrades Rate us on Facebook Rate us on Yahoo! Rate us on WebMD
Contact Us